Introduction On 1 July 2021, France made changes to its long-standing Authorization for Temporary Us...
Read moreIntroduction Following Brexit, regulatory oversight in the UK has switched from the European Medicin...
Read moreAccording to the National Agency for Drug Safety, there are currently four treatments available thro...
Read moreThe report looks at four possible scenarios including most notably the creation of a “grande Sécu...
Read moreThe association proposes concentrating efforts around four primary objectives.
Read moreNotably, the early access scheme was reformed with effect from 1st July 2021.
Read moreThe 2021 Social Security Law made provision for overhauling the early scheme in France. As of 1st Ju...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe final details of the decree may differ from those detailed above, making the precise nature of t...
Read more